Oruka Therapeutics, Inc. (ORKA) stock
ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
$95.81−1.76 (-1.80%)
Close on Nov 20, 2026Market cap $6.34BP/E –Yield –
Oruka Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Oruka Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$101.15M. For fiscal 2025 it was -$88.42M. The highest annual figure on record is -$4.81M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$88.42M | – |
| FY2023 | Dec 31, 2023 | -$5.01M | – |
| FY2022 | Dec 31, 2022 | -$10.91M | – |
| FY2021 | Dec 31, 2021 | -$18.81M | – |
| FY2020 | Dec 31, 2020 | -$7.74M | – |
| FY2019 | Dec 31, 2019 | -$4.81M | – |
| FY2018 | Dec 31, 2018 | -$8.25M | – |
| FY2017 | Dec 31, 2017 | -$17.48M | – |
| FY2016 | Dec 31, 2016 | -$15.00M | – |
| FY2015 | Dec 31, 2015 | -$10.55M | – |
| FY2014 | Dec 31, 2014 | -$9.43M | – |
| FY2013 | Dec 31, 2013 | -$5.32M | – |
| FY2011 | Dec 31, 2011 | -$6.98M | – |
| FY2010 | Dec 31, 2010 | -$8.33M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$33.15M | – |
| Q1 FY2026 | Mar 31, 2026 | -$23.65M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.66M | – |
| Q3 FY2025 | Sep 30, 2025 | -$21.70M | – |
| Q2 FY2025 | Jun 30, 2025 | -$23.18M | – |
| Q1 FY2025 | Mar 31, 2025 | -$20.88M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.49M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.50M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.62M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.30M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.95M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.88M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.74M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.23M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.01M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.69M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.16M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.34M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.58M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.25M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.07M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.97M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.85M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.74M | – |
| Q2 FY2016 | Jun 30, 2016 | -$3.53M | – |
See a number that looks wrong?